Autoimmune pancreatitis (AIP) Pancreatic cancer (PC: as a comparative disease)
Conditions
Interventions
None listed
Sponsors
Department of Radiology, Kanazawa University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Pts. diagnosed as AIP or PC 2) Pts. who were performed dynamic MDCT or MRI, followed pancreatic resection within 3 months, during 2005.1 - 2014.12 3) Imaging data of MDCT and/or MRI and histopathological specimens can be provided for central evaluation 4) Diagnostic standard: AIP: Consensus statement by Deshpande V et al. (Modern Pathology 2012) PC: Japanese guideline of medical practice for pancreatic cancer 2013 5) Accept regardless of age and gender
Exclusion criteria
Exclusion criteria: 1) AIP pts. with pre-operative steroid treatment 2) PC pts. with pre-operative chemotherapy or radiation treatment 3) Pts. who were doubly registered 4) Any other pts. who are determined ineligible for this study by investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostically and histopathologically differential features between AIP and PC 1) Independent evaluation of all imaging data (mainly CT/MRI) and pathological specimens by radiologists and pathologists, respectively, regarding the following items. --Major evaluation items on diagnostic images-- - General findings - Findings inside pancreas - Findings in margin of the lesion - Findings in pancreatic duct --Major evaluation items on histopathological findings-- - Findings in pancreas 2) Evaluation of differential features and similarities between AIP and PC by intercomparison based on the consensus between the radiologists and the pathologists. | — |
Countries
Japan
Contacts
Public ContactDai Inoue
Kanazawa University Hospital Department of Radiology
Outcome results
None listed